Roche Holding AG ( RHHBF) - Key Metrics
RHHBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $38.53 | $2.54 | $14.69 | $12.42 |
| 2024Q2 | $38.49 | $7.83 | $9.90 | $7.75 |
| 2023Q4 | $36.30 | $5.47 | $9.92 | $6.56 |
| 2023Q2 | $37.27 | $8.93 | $9.50 | $7.03 |
| 2022Q4 | $38.77 | $4.87 | $10.77 | $7.61 |
RHHBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | 25.16 |
| 2024Q2 | 122.24% | 7.98 |
| 2023Q4 | 0.62% | 11.17 |
| 2023Q2 | 106.73% | 7.65 |
| 2022Q4 | ? | 14.92 |
RHHBF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q4 | 4.86% | ? |
| 2024Q2 | 3.10% | 3.83% |
| 2023Q4 | 2.68% | 0.01% |
| 2023Q2 | 2.57% | 3.49% |
| 2022Q4 | 2.62% | ? |
RHHBF
Price: $410.73
Dividend Yield: 3.14%
Forward Dividend Yield: 6.15%
Payout Ratio: 70.22%
Dividend Per Share: 25.28 USD
Earnings Per Share: 19.81 USD
P/E Ratio: 23.47
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Market Capitalization: 323.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 30.00%
DGR5: 23.68%
DGR10: 12.92%
DGR20: 12.90%